+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Veterinary Antibiotics Market by Class (Aminoglycosides, Amphenicols, Cephalosporins), Animal Type (Companion Animals, Livestock), End-user, Therapeutic Areas - Global Forecast 2025-2030- Product Image
Veterinary Antibiotics Market by Class (Aminoglycosides, Amphenicols, Cephalosporins), Animal Type (Companion Animals, Livestock), End-user, Therapeutic Areas - Global Forecast 2025-2030- Product Image
Sale

Veterinary Antibiotics Market by Class (Aminoglycosides, Amphenicols, Cephalosporins), Animal Type (Companion Animals, Livestock), End-user, Therapeutic Areas - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • November 2024
  • Region: Global
  • 360iResearch™
  • ID: 6021513
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Veterinary Antibiotics Market grew from USD 3.38 billion in 2023 to USD 3.68 billion in 2024. It is expected to continue growing at a CAGR of 9.01%, reaching USD 6.18 billion by 2030.

The scope of veterinary antibiotics encompasses a variety of medications used to treat bacterial infections in animals, ensuring their health and productivity across different sectors, including livestock, poultry, aquaculture, and companion animals. The necessity of veterinary antibiotics lies in their critical role in managing and preventing infectious diseases, thereby supporting animal welfare and the global food supply chain. Applications are diverse, ranging from therapeutic, prophylactic, to growth-promotive uses, although the latter is subject to regulatory scrutiny in many regions due to antibiotic resistance concerns. The end-use sectors predominantly include veterinary hospitals, clinics, and animal farms.

Key growth factors in this market include the increasing demand for animal-derived food products, rising awareness about animal health, and the growing pet population. Advances in veterinary healthcare and diagnostic technologies also support market expansion. However, the market faces limitations such as stringent regulations regarding antibiotic use, especially concerning antimicrobial resistance. Public health concerns and the potential development of resistance require companies to innovate and adapt, pushing for the development of alternative treatments such as probiotics, vaccines, and phytogenics.

Opportunities in the market can be harnessed by focusing on antibiotic alternatives and precision livestock farming, which includes digital tools and data analytics to optimize health and productivity with minimal drug use. Research in genomic tools and immune-enhancing feed additives holds promise for business growth. The nature of the market is dynamic and driven by regulatory frameworks, scientific advances, and consumer awareness. Coupled with a trend towards sustainable practices, companies are encouraged to invest in R&D that aligns with these emerging priorities. Innovation should strive towards balancing efficient animal healthcare with responsible use practices to mitigate resistance risks, thus ensuring long-term market viability and public health safety.

Understanding Market Dynamics in the Veterinary Antibiotics Market

The Veterinary Antibiotics Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Main forces driving the increased adoption of veterinary antibiotics across global veterinary practices
    • Key elements propelling growth in the veterinary antibiotics market within the dynamic healthcare sector
    • Prominent determinants boosting the utilization of veterinary antibiotics in preventive veterinary care
  • Market Restraints
    • Key challenges and constraints shaping the market trajectory of veterinary antibiotics
    • Identifying the hurdles impacting the innovation and supply of veterinary antibiotics
    • Analyzing the restrictions affecting the strategic advancement of the veterinary antibiotics space
  • Market Opportunities
    • Antibiotics for aquaculture providing a growth opportunity due to the increasing focus on seafood health
    • Emergence of innovative, natural antibiotics that reduce antibiotic resistance while ensuring efficacy
    • Increasing pet ownership driving the demand for more veterinary antibiotics to ensure animal health
  • Market Challenges
    • Facilitating collaboration between veterinary professionals and pharmaceutical companies for better solutions
    • Ensuring consistent supply chain efficiency amidst disruptions affecting raw materials and production
    • Managing public perception and misinformation about the role of antibiotics in veterinary medicine

Exploring Porter’s Five Forces for the Veterinary Antibiotics Market

Porter’s Five Forces framework further strengthens the insights of the Veterinary Antibiotics Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Veterinary Antibiotics Market

External macro-environmental factors deeply influence the performance of the Veterinary Antibiotics Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Veterinary Antibiotics Market

The Veterinary Antibiotics Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Veterinary Antibiotics Market

The Veterinary Antibiotics Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Veterinary Antibiotics Market

The Veterinary Antibiotics Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Veterinary Antibiotics Market, highlighting leading vendors and their innovative profiles. These include Bayer Animal Health, Boehringer Ingelheim Vetmedica, Inc., Ceva Animal Health, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Huvepharma Inc., Kyoritsu Seiyaku Corporation, Merck Animal Health, Neogen Corporation, Norbrook Laboratories Ltd, Phibro Animal Health Corporation, Vetoquinol USA Inc., Virbac Corporation, Zagro Asia Limited, and Zoetis Inc.

Market Segmentation & Coverage

This research report categorizes the Veterinary Antibiotics Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Class
    • Aminoglycosides
      • Amikacin
      • Apramycin
      • Gentamicin
      • Kanamycin
      • Neomycin
    • Amphenicols
      • Florfenicol
      • Thiamphenicol
    • Cephalosporins
      • Cefalexin
      • Cefalonium
      • Cefazolin
      • Cefovecin
      • Ceftiofur
      • Ceftriaxone
    • Fluoroquinolones
      • Ciprofloxacin
      • Danofloxacin
      • Difloxacin
      • Enrofloxacin
      • Norfloxacin
      • Orbifloxacin
    • Macrolides
      • Azithromycin
      • Clarithromycin
      • Erythromycin
      • Gamithromycin
      • Spiramycin
      • Tilmicosin
      • Tulathromycin
      • Tylosin
    • Other Quinolones
      • Oxolinic Acid
      • Pipemidic Acid
    • Penicillins
      • Amoxicillin
      • Ampicillin
      • Cloxacillin
      • Oxacillin
      • Penicillin G
      • Penicillin V
    • Polymixins
      • Colistin/Polymyxin E
      • Polymyxin B
    • Sulfonamides
      • Sulfadiazine
      • Sulfamerazine
      • Sulfamethizole
      • Sulfamethoxazole
      • Sulfasalazine
    • Tetracyclines
      • Chlortetracycline
      • Doxycycline
      • Oxytetracycline
      • Tetracycline
  • Animal Type
    • Companion Animals
      • Cats
      • Dogs
    • Livestock
      • Cattle
      • Poultry
      • Sheep & Goats
      • Swine
  • End-User
    • Animal Production Facilities
    • Household Pet Owners
    • Veterinary Clinics
  • Therapeutic Areas
    • Dermatological Infections
    • Gastrointestinal Infections
    • Reproductive System Infections
    • Respiratory Infections
    • Soft Tissue & Wound Infections
    • Systemic Infections
    • Urinary Tract Infections
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States (California, Florida, Illinois, New York, Ohio, Pennsylvania, Texas)
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  • Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  • Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  • Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  • Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  • Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  • What is the current size of the market, and how is it expected to grow?
  • Which products, segments, and regions present the most attractive investment opportunities?
  • What are the prevailing technology trends and regulatory factors influencing the market?
  • How do top vendors rank regarding market share and competitive positioning?
  • What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Main forces driving the increased adoption of veterinary antibiotics across global veterinary practices
5.1.1.2. Key elements propelling growth in the veterinary antibiotics market within the dynamic healthcare sector
5.1.1.3. Prominent determinants boosting the utilization of veterinary antibiotics in preventive veterinary care
5.1.2. Restraints
5.1.2.1. Key challenges and constraints shaping the market trajectory of veterinary antibiotics
5.1.2.2. Identifying the hurdles impacting the innovation and supply of veterinary antibiotics
5.1.2.3. Analyzing the restrictions affecting the strategic advancement of the veterinary antibiotics space
5.1.3. Opportunities
5.1.3.1. Antibiotics for aquaculture providing a growth opportunity due to the increasing focus on seafood health
5.1.3.2. Emergence of innovative, natural antibiotics that reduce antibiotic resistance while ensuring efficacy
5.1.3.3. Increasing pet ownership driving the demand for more veterinary antibiotics to ensure animal health
5.1.4. Challenges
5.1.4.1. Facilitating collaboration between veterinary professionals and pharmaceutical companies for better solutions
5.1.4.2. Ensuring consistent supply chain efficiency amidst disruptions affecting raw materials and production
5.1.4.3. Managing public perception and misinformation about the role of antibiotics in veterinary medicine
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Veterinary Antibiotics Market, by Class
6.1. Introduction
6.2. Aminoglycosides
6.2.1. Amikacin
6.2.2. Apramycin
6.2.3. Gentamicin
6.2.4. Kanamycin
6.2.5. Neomycin
6.3. Amphenicols
6.3.1. Florfenicol
6.3.2. Thiamphenicol
6.4. Cephalosporins
6.4.1. Cefalexin
6.4.2. Cefalonium
6.4.3. Cefazolin
6.4.4. Cefovecin
6.4.5. Ceftiofur
6.4.6. Ceftriaxone
6.5. Fluoroquinolones
6.5.1. Ciprofloxacin
6.5.2. Danofloxacin
6.5.3. Difloxacin
6.5.4. Enrofloxacin
6.5.5. Norfloxacin
6.5.6. Orbifloxacin
6.6. Macrolides
6.6.1. Azithromycin
6.6.2. Clarithromycin
6.6.3. Erythromycin
6.6.4. Gamithromycin
6.6.5. Spiramycin
6.6.6. Tilmicosin
6.6.7. Tulathromycin
6.6.8. Tylosin
6.7. Other Quinolones
6.7.1. Oxolinic Acid
6.7.2. Pipemidic Acid
6.8. Penicillins
6.8.1. Amoxicillin
6.8.2. Ampicillin
6.8.3. Cloxacillin
6.8.4. Oxacillin
6.8.5. Penicillin G
6.8.6. Penicillin V
6.9. Polymixins
6.9.1. Colistin/Polymyxin E
6.9.2. Polymyxin B
6.10. Sulfonamides
6.10.1. Sulfadiazine
6.10.2. Sulfamerazine
6.10.3. Sulfamethizole
6.10.4. Sulfamethoxazole
6.10.5. Sulfasalazine
6.11. Tetracyclines
6.11.1. Chlortetracycline
6.11.2. Doxycycline
6.11.3. Oxytetracycline
6.11.4. Tetracycline
7. Veterinary Antibiotics Market, by Animal Type
7.1. Introduction
7.2. Companion Animals
7.2.1. Cats
7.2.2. Dogs
7.3. Livestock
7.3.1. Cattle
7.3.2. Poultry
7.3.3. Sheep & Goats
7.3.4. Swine
8. Veterinary Antibiotics Market, by End-User
8.1. Introduction
8.2. Animal Production Facilities
8.3. Household Pet Owners
8.4. Veterinary Clinics
9. Veterinary Antibiotics Market, by Therapeutic Areas
9.1. Introduction
9.2. Dermatological Infections
9.3. Gastrointestinal Infections
9.4. Reproductive System Infections
9.5. Respiratory Infections
9.6. Soft Tissue & Wound Infections
9.7. Systemic Infections
9.8. Urinary Tract Infections
10. Americas Veterinary Antibiotics Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Veterinary Antibiotics Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Veterinary Antibiotics Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. VETERINARY ANTIBIOTICS MARKET MULTI-CURRENCY
FIGURE 2. VETERINARY ANTIBIOTICS MARKET MULTI-LANGUAGE
FIGURE 3. VETERINARY ANTIBIOTICS MARKET RESEARCH PROCESS
FIGURE 4. VETERINARY ANTIBIOTICS MARKET SIZE, 2023 VS 2030
FIGURE 5. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 6. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2023 VS 2030 (%)
FIGURE 9. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
FIGURE 11. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 13. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY THERAPEUTIC AREAS, 2023 VS 2030 (%)
FIGURE 15. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY THERAPEUTIC AREAS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 19. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC VETERINARY ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC VETERINARY ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. VETERINARY ANTIBIOTICS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 25. VETERINARY ANTIBIOTICS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. VETERINARY ANTIBIOTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. VETERINARY ANTIBIOTICS MARKET DYNAMICS
TABLE 7. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY AMIKACIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY APRAMYCIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY GENTAMICIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY KANAMYCIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY NEOMYCIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPHENICOLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY FLORFENICOL, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY THIAMPHENICOL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPHENICOLS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CEFALEXIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CEFALONIUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CEFAZOLIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CEFOVECIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CEFTIOFUR, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CEFTRIAXONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CIPROFLOXACIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY DANOFLOXACIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY DIFLOXACIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY ENROFLOXACIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY NORFLOXACIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY ORBIFLOXACIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY MACROLIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY AZITHROMYCIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CLARITHROMYCIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY ERYTHROMYCIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY GAMITHROMYCIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY SPIRAMYCIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY TILMICOSIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY TULATHROMYCIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY TYLOSIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY OTHER QUINOLONES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY OXOLINIC ACID, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY PIPEMIDIC ACID, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY OTHER QUINOLONES, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY AMOXICILLIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPICILLIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CLOXACILLIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY OXACILLIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLIN G, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLIN V, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMIXINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY COLISTIN/POLYMYXIN E, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMYXIN B, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMIXINS, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFADIAZINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFAMERAZINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFAMETHIZOLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFAMETHOXAZOLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFASALAZINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY TETRACYCLINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CHLORTETRACYCLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY DOXYCYCLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY OXYTETRACYCLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY TETRACYCLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY DOGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CATTLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY SHEEP & GOATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY SWINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 86. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL PRODUCTION FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 87. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY HOUSEHOLD PET OWNERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 88. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 89. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 90. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY DERMATOLOGICAL INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 91. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 92. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY REPRODUCTIVE SYSTEM INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 93. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY RESPIRATORY INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 94. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY SOFT TISSUE & WOUND INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 95. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY SYSTEMIC INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 96. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY URINARY TRACT INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPHENICOLS, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY OTHER QUINOLONES, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 105. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMIXINS, 2018-2030 (USD MILLION)
TABLE 106. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 107. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 108. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 109. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 110. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 111. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 112. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 113. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPHENICOLS, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY OTHER QUINOLONES, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMIXINS, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPHENICOLS, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY OTHER QUINOLONES, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMIXINS, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 146. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 147. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 148. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPHENICOLS, 2018-2030 (USD MILLION)
TABLE 149. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 150. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2030 (USD MILLION)
TABLE 151. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 152. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY OTHER QUINOLONES, 2018-2030 (USD MILLION)
TABLE 153. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 154. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMIXINS, 2018-2030 (USD MILLION)
TABLE 155. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 156. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 157. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 158. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 159. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 160. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 161. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 162. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 163. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 164. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPHENICOLS, 2018-2030 (USD MILLION)
TABLE 165. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 166. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2030 (USD MILLION)
TABLE 167. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 168. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY OTHER QUINOLONES, 2018-2030 (USD MILLION)
TABLE 169. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 170. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMIXINS, 2018-2030 (USD MILLION)
TABLE 171. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 172. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 173. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 174. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 175. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 176. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 177. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 178. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 179. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 180. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPHENICOLS, 2018-2030 (USD MILLION)
TABLE 181. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 182. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2030 (USD MILLION)
TABLE 183. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 184. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY OTHER QUINOLONES, 2018-2030 (USD MILLION)
TABLE 185. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 186. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMIXINS, 2018-2030 (USD MILLION)
TABLE 187. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 188. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 189. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 190. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 191. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 192. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 193. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 194. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 195. ASIA-PACIFIC VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 196. ASIA-PACIFIC VETERINARY ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 197. ASIA-PACIFIC VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPHENICOLS, 2018-2030 (USD MILLION)
TABLE 198. ASIA-PACIFIC VETERINARY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 199. ASIA-PACIFIC VETERINARY ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2030 (USD MILLION)
TABLE 200. ASIA-PACIFIC VETERINARY ANTIBIOTICS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 201. ASIA-PACIFIC VETERINARY ANTIBIOTICS MARKET SIZE, BY OTHER QUINOLONES, 2018-2030 (USD MILLION)
TABLE 202. ASIA-PACIFIC VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 203. ASIA-PACIFIC VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMIXINS, 2018-2030 (USD MILLION)
TABLE 204. ASIA-PACIFIC VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 205. ASIA-PACIFIC VETERINARY ANTIBIOTICS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 206. ASIA-PACIFIC VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 207. ASIA-PACIFIC VETERINARY ANTIBIOTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 208. ASIA-PACIFIC VETERINARY ANTIBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 209. ASIA-PACIFIC VETERINARY ANTIBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 210. ASIA-PACIFIC VETERINARY ANTIBIOTICS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 211. ASIA-PACIFIC VETERINARY ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 212. AUSTRALIA VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 213. AUSTRALIA VETERINARY ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 214. AUSTRALIA VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPHENICOLS, 2018-2030 (USD MILLION)
TABLE 215. AUSTRALIA VETERINARY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 216. AUSTRALIA VETERINARY ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2030 (USD MILLION)
TABLE 217. AUSTRALIA VETERINARY ANTIBIOTICS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 218. AUSTRALIA VETERINARY ANTIBIOTICS MARKET SIZE, BY OTHER QUINOLONES, 2018-2030 (USD MILLION)
TABLE 219. AUSTRALIA VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 220. AUSTRALIA VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMIXINS, 2018-2030 (USD MILLION)
TABLE 221. AUSTRALIA VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 222. AUSTRALIA VETERINARY ANTIBIOTICS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 223. AUSTRALIA VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 224. AUSTRALIA VETERINARY ANTIBIOTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 225. AUSTRALIA VETERINARY ANTIBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 226. AUSTRALIA VETERINARY ANTIBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 227. AUSTRALIA VETERINARY ANTIBIOTICS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 228. CHINA VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 229. CHINA VETERINARY ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 230. CHINA VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPHENICOLS, 2018-2030 (USD MILLION)
TABLE 231. CHINA VETERINARY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 232. CHINA VETERINARY ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2030 (USD MILLION)
TABLE 233. CHINA VETERINARY ANTIBIOTICS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 234. CHINA VETERINARY ANTIBIOTICS MARKET SIZE, BY OTHER QUINOLONES, 2018-2030 (USD MILLION)
TABLE 235. CHINA VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 236. CHINA VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMIXINS, 2018-2030 (USD MILLION)
TABLE 237. CHINA VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 238. CHINA VETERINARY ANTIBIOTICS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 239. CHINA VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 240. CHINA VETERINARY ANTIBIOTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 241. CHINA VETERINARY ANTIBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 242. CHINA VETERINARY ANTIBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 243. CHINA VETERINARY ANTIBIOTICS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 244. INDIA VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 245. INDIA VETERINARY ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 246. INDIA VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPHENICOLS, 2018-2030 (USD MILLION)
TABLE 247. INDIA VETERINARY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 248. INDIA VETERINARY ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2030 (USD MILLION)
TABLE 249. INDIA VETERINARY ANTIBIOTICS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 250. INDIA VETERINARY ANTIBIOTICS MARKET SIZE, BY OTHER QUINOLONES, 2018-2030 (USD MILLION)
TABLE 251. INDIA VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 252. INDIA VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMIXINS, 2018-2030 (USD MILLION)
TABLE 253. INDIA VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 254. INDIA VETERINARY ANTIBIOTICS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 255. INDIA VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 256. INDIA VETERINARY ANTIBIOTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 257. INDIA VETERINARY ANTIBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 258. INDIA VETERINARY ANTIBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 259. INDIA VETERINARY ANTIBIOTICS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 260. INDONESIA VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 261. INDONESIA VETERINARY ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 262. INDONESIA VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPHENICOLS, 2018-2030 (USD MILLION)
TABLE 263. INDONESIA VETERINARY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 264. INDONESIA VETERINARY ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2030 (USD MILLION)
TABLE 265. INDONESIA VETERINARY ANTIBIOTICS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 266. INDONESIA VETERINARY ANTIBIOTICS MARKET SIZE, BY OTHER QUINOLONES, 2018-2030 (USD MILLION)
TABLE 267. INDONESIA VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 268. INDONESIA VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMIXINS, 2018-2030 (USD MILLION)
TABLE 269. INDONESIA VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 270. INDONESIA VETERINARY ANTIBIOTICS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 271. INDONESIA VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 272. INDONESIA VETERINARY ANTIBIOTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 273. INDONESIA VETERINARY ANTIBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 274. INDONESIA VETERINARY ANTIBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 275. INDONESIA VETERINARY ANTIBIOTICS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 276. JAPAN VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 277. JAPAN VETERINARY ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 278. JAPAN VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPHENICOLS, 2018-2030 (USD MILLION)
TABLE 279. JAPAN VETERINARY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 280. JAPAN VETERINARY ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2030 (USD MILLION)
TABLE 281. JAPAN VETERINARY ANTIBIOTICS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 282. JAPAN VETERINARY ANTIBIOTICS MARKET SIZE, BY OTHER QUINOLONES, 2018-2030 (USD MILLION)
TABLE 283. JAPAN VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 284. JAPAN VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMIXINS, 2018-2030 (USD MILLION)
TABLE 285. JAPAN VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 286. JAPAN VETERINARY ANTIBIOTICS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 287. JAPAN VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 288. JAPAN VETERINARY ANTIBIOTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 289. JAPAN VETERINARY ANTIBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 290. JAPAN VETERINARY ANTIBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 291. JAPAN VETERINARY ANTIBIOTICS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 292. MALAYSIA VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 293. MALAYSIA VETERINARY ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 294. MALAYSIA VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPHENICOLS, 2018-2030 (USD MILLION)
TABLE 295. MALAYSIA VETERINARY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 296. MALAYSIA VETERINARY ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2030 (USD MILLION)
TABLE 297. MALAYSIA VETERINARY ANTIBIOTICS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 298. MALAYSIA VETERINARY ANTIBIOTICS MARKET SIZE, BY OTHER QUINOLONES, 2018-2030 (USD MILLION)
TABLE 299. MALAYSIA VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 300. MALAYSIA VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMIXINS, 2018-2030 (USD MILLION)
TABLE 301. MALAYSIA VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 302. MALAYSIA VETERINARY ANTIBIOTICS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 303. MALAYSIA VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 304. MALAYSIA VETERINARY ANTIBIOTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 305. MALAYSIA VETERINARY ANTIBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 306. MALAYSIA VETERINARY ANTIBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 307. MALAYSIA VETERINARY ANTIBIOTICS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 308. PHILIPPINES VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 309. PHILIPPINES VETERINARY ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 310. PHILIPPINES VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPHENICOLS, 2018-2030 (USD MILLION)
TABLE 311. PHILIPPINES VETERINARY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 312. PHILIPPINES VETERINARY ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2030 (USD MILLION)
TABLE 313. PHILIPPINES VETERINARY ANTIBIOTICS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 314. PHILIPPINES VETERINARY ANTIBIOTICS MARKET SIZE, BY OTHER QUINOLONES, 2018-2030 (USD MILLION)
TABLE 315. PHILIPPINES VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 316. PHILIPPINES VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMIXINS, 2018-2030 (USD MILLION)
TABLE 317. PHILIPPINES VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 318. PHILIPPINES VETERINARY ANTIBIOTICS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 319. PHILIPPINES VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 320. PHILIPPINES VETERINARY ANTIBIOTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 321. PHILIPPINES VETERINARY ANTIBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 322. PHILIPPINES VETERINARY ANTIBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 323. PHILIPPINES VETERINARY ANTIBIOTICS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 324. SINGAPORE VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 325. SINGAPORE VETERINARY ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 326. SINGAPORE VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPHENICOLS, 2018-2030 (USD MILLION)
TABLE 327. SINGAPORE VETERINARY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 328. SINGAPORE VETERINARY ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2030 (USD MILLION)
TABLE 329. SINGAPORE VETERINARY ANTIBIOTICS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 330. SINGAPORE VETERINARY ANTIBIOTICS MARKET SIZE, BY OTHER QUINOLONES, 2018-2030 (USD MILLION)
TABLE 331. SINGAPORE VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 332. SINGAPORE VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMIXINS, 2018-2030 (USD MILLION)
TABLE 333. SINGAPORE VETERINARY ANTIBIOTICS MAR

Companies Mentioned

  • Bayer Animal Health
  • Boehringer Ingelheim Vetmedica, Inc.
  • Ceva Animal Health
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Huvepharma Inc.
  • Kyoritsu Seiyaku Corporation
  • Merck Animal Health
  • Neogen Corporation
  • Norbrook Laboratories Ltd
  • Phibro Animal Health Corporation
  • Vetoquinol USA Inc.
  • Virbac Corporation
  • Zagro Asia Limited
  • Zoetis Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages182
PublishedNovember 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 3.68 billion
Forecasted Market Value ( USD ) by 2030 $ 6.18 billion
Compound Annual Growth Rate9.0%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Veterinary Antibiotics Market Size, Share & Trends Analysis Report by Animal Type (Pigs, Cattle, Sheep & Goats, Poultry), Drug Class (Tetracyclines, Penicillins), Dosage Form, Region, and Segment Forecasts, 2025-2030 - Product Image

Veterinary Antibiotics Market Size, Share & Trends Analysis Report by Animal Type (Pigs, Cattle, Sheep & Goats, Poultry), Drug Class (Tetracyclines, Penicillins), Dosage Form, Region, and Segment Forecasts, 2025-2030

  • Report
  • 258 Pages
  • Global
From
Veterinary Antibiotics Global Market Report 2024 - Product Image

Veterinary Antibiotics Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Veterinary Antibiotics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Veterinary Antibiotics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 86 Pages
  • Global
From
2024 Global Forecast for Veterinary Antibiotic Preparations, Tetracyclines, and Other Antibiotics (2025-2030 Outlook) - Manufacturing & Markets Report - Product Image

2024 Global Forecast for Veterinary Antibiotic Preparations, Tetracyclines, and Other Antibiotics (2025-2030 Outlook) - Manufacturing & Markets Report

  • Report
  • 132 Pages
  • Global
From
2024 Global Forecast for Veterinary Antibiotic Preparations, Penicillins (2025-2030 Outlook) - Manufacturing & Markets Report - Product Image

2024 Global Forecast for Veterinary Antibiotic Preparations, Penicillins (2025-2030 Outlook) - Manufacturing & Markets Report

  • Report
  • 132 Pages
  • Global
From

About the Market

The Veterinary Antibiotics market is a segment of the Animal Healthcare/Veterinary industry that focuses on the production and distribution of antibiotics for use in animals. Veterinary antibiotics are used to treat a variety of bacterial infections in animals, including respiratory, gastrointestinal, and urinary tract infections. They are also used to prevent and control the spread of infectious diseases in animals. Veterinary antibiotics are available in a variety of forms, including tablets, capsules, liquids, and injectables. Veterinary antibiotics are regulated by the Food and Drug Administration (FDA) and must meet certain safety and efficacy standards. Veterinary antibiotics are typically prescribed by veterinarians and dispensed by pharmacies. In some cases, they may be available over-the-counter. Some companies in the Veterinary Antibiotics market include Bayer, Merck, Zoetis, Elanco, and Boehringer Ingelheim. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.